Literature DB >> 16868501

Determinants of survival without antiretroviral therapy after infancy in HIV-1-infected Zambian children in the CHAP Trial.

A Sarah Walker1, Veronica Mulenga, Frederick Sinyinza, Kennedy Lishimpi, Andrew Nunn, Chifumbe Chintu, Diana M Gibb.   

Abstract

BACKGROUND: There are few data on predictors of HIV progression in untreated children in resource-limited settings.
METHODS: Children with HIV Antibiotic Prophylaxis (CHAP) was a randomized trial comparing cotrimoxazole prophylaxis with placebo in HIV-infected Zambian children. The prognostic value of baseline characteristics was investigated using Cox models.
RESULTS: Five hundred fourteen children aged 1 to 14 (median 5.5) years contributed 607 years follow-up (maximum 2.6 years). Half were boys, and in 67%, the mother was the primary carer; at baseline, median CD4 percentage was 11% and weight was less than third percentile in 67%. One hundred sixty-five children died (27.2 per 100 years at risk; 95% confidence interval 23.3-31.6). Low weight-for-age, CD4 percentage, hemoglobin, mother as primary carer, current malnutrition, and previous hospital admissions for respiratory tract infections or recurrent severe bacterial infections were independent predictors of poorer survival, whereas oral candidiasis predicted poorer survival only when baseline CD4 percentage was not considered. Mortality rates per 100 child years of 44.5 (37.2-53.2), 14.7 (10.9-19.8), and 2.3 (0.3-16.7) were associated with new World Health Organization stages 4, 3, and 1/2, respectively, applied retrospectively; very low weight-for-age was the only staging feature for 42% of stage 4 children.
CONCLUSIONS: Malnutrition and hospitalizations for respiratory/bacterial infections predict mortality independent of immunosuppression, suggesting that they capture HIV- and non-HIV-related mortality, whereas oral candidiasis is a proxy for immunosuppression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16868501     DOI: 10.1097/01.qai.0000226334.34717.dc

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  25 in total

1.  Risk factors affecting child cognitive development: a summary of nutrition, environment, and maternal-child interaction indicators for sub-Saharan Africa.

Authors:  N D Ford; A D Stein
Journal:  J Dev Orig Health Dis       Date:  2015-09-11       Impact factor: 2.401

2.  Immunologic risk factors for early mortality after starting antiretroviral therapy in HIV-infected Zambian children.

Authors:  Kaitlin Rainwater-Lovett; Hope C Nkamba; Mwangelwa Mubiana-Mbewe; Carolyn Bolton Moore; William J Moss
Journal:  AIDS Res Hum Retroviruses       Date:  2012-10-31       Impact factor: 2.205

Review 3.  Perinatally acquired HIV infection in adolescents from sub-Saharan Africa: a review of emerging challenges.

Authors:  Elizabeth D Lowenthal; Sabrina Bakeera-Kitaka; Tafireyi Marukutira; Jennifer Chapman; Kathryn Goldrath; Rashida A Ferrand
Journal:  Lancet Infect Dis       Date:  2014-01-07       Impact factor: 25.071

Review 4.  Severe malnutrition and metabolic complications of HIV-infected children in the antiretroviral era: clinical care and management in resource-limited settings.

Authors:  Philippa M Musoke; Pamela Fergusson
Journal:  Am J Clin Nutr       Date:  2011-11-16       Impact factor: 7.045

5.  Adolescent HIV--cause for concern in Southern Africa.

Authors:  Glenda E Gray
Journal:  PLoS Med       Date:  2010-02-02       Impact factor: 11.069

6.  Effect of multiple micronutrient supplementation on survival of HIV-infected children in Uganda: a randomized, controlled trial.

Authors:  Grace Ndeezi; Thorkild Tylleskär; Christopher M Ndugwa; James K Tumwine
Journal:  J Int AIDS Soc       Date:  2010-06-03       Impact factor: 5.396

7.  Causes of acute hospitalization in adolescence: burden and spectrum of HIV-related morbidity in a country with an early-onset and severe HIV epidemic: a prospective survey.

Authors:  Rashida A Ferrand; Tsitsi Bandason; Praise Musvaire; Natasha Larke; Kusum Nathoo; Hilda Mujuru; Chiratidzo E Ndhlovu; Shungu Munyati; Frances M Cowan; Diana M Gibb; Elizabeth L Corbett
Journal:  PLoS Med       Date:  2010-02-02       Impact factor: 11.069

8.  Skin disease among human immunodeficiency virus-infected adolescents in Zimbabwe: a strong indicator of underlying HIV infection.

Authors:  Sara Lowe; Rashida A Ferrand; Rachael Morris-Jones; Jon Salisbury; Nicholas Mangeya; Munyaradzi Dimairo; Robert F Miller; Elizabeth L Corbett
Journal:  Pediatr Infect Dis J       Date:  2010-04       Impact factor: 2.129

9.  Survival from 9 months of age among HIV-infected and uninfected Zambian children prior to the availability of antiretroviral therapy.

Authors:  Catherine G Sutcliffe; Susana Scott; Nanthalile Mugala; Zaza Ndhlovu; Mwaka Monze; Thomas C Quinn; Simon Cousens; Diane E Griffin; William J Moss
Journal:  Clin Infect Dis       Date:  2008-09-15       Impact factor: 9.079

10.  Anemia and growth failure among HIV-infected children in India: a retrospective analysis.

Authors:  Anita Shet; Saurabh Mehta; Nirmala Rajagopalan; Chitra Dinakar; Elango Ramesh; N M Samuel; C K Indumathi; Wafaie W Fawzi; Anura V Kurpad
Journal:  BMC Pediatr       Date:  2009-06-16       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.